P1 ‐085: Utilization and effectiveness of Elbasvir/Grazoprevir (EBR/GZR) in treatment Naïve (TN) genotype 1a (G1a) chronic hepatitis C virus (HCV) patients with/without baseline NS5A resistance‐associated substitutions (RASs)

Journal of Viral Hepatitis,Volume 25, Issue S2, Page 66-66, June 2018.

Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research